InVivo Therapeutics Holdings Corp.

NVIV

US46186M6057

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 03:33:29 2024-04-26 pm EDT			5-day change	1st Jan Change
0.37 ^USD	+2.78%		+2.78%	-49.32%

Apr. 16	North American Morning Briefing : Powell Comments, -2-	DJ
Apr. 02	North American Morning Briefing : Stocks Seen -2-	DJ

InVivo: Q1 Earnings Snapshot

May 11, 2022 at 03:24 pm EDT

CAMBRIDGE, Mass. (AP) _ InVivo Therapeutics Holdings Corp. (NVIV) on Tuesday reported a loss of $2.7 million in its first quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.94.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVIV at https://www.zacks.com/ap/NVIV

Latest news about InVivo Therapeutics Holdings Corp.

North American Morning Briefing : Powell Comments, -2-	Apr. 16	DJ
North American Morning Briefing : Stocks Seen -2-	Apr. 02	DJ
North American Morning Briefing : Markets Steady -2-	Mar. 26	DJ
North American Morning Briefing : Stock Futures -2-	Mar. 19	DJ
InVivo Therapeutics Holdings Corp.(OTCPK:NVIV.Q) dropped from NASDAQ Composite Index	Feb. 11	CI
InVivo Therapeutics Holdings Corp.(NasdaqCM:NVIV) dropped from S&P TMI Index	Feb. 06	CI
Motion for Joint Administration Approved for Invivo Therapeutics Corporation	Feb. 05	CI
Motion for Asset Sale Filed by Invivo Therapeutics Corporation	Jan. 31	CI
Motion for Joint Administration Filed by Invivo Therapeutics Corporation	Jan. 31	CI
Invivo Therapeutics Corporation Filed for Bankruptcy	Jan. 31	CI
Invivo Therapeutics Holdings Corp. Announces Resignation of Daniel R. Marshak from the Board of Directors	Nov. 22	CI
InVivo to open Saudi office as adapts to global grain shifts	Nov. 15	RE
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Australia's United Malt agrees to $1 bln takeover offer from France's InVivo	23-07-02	RE
Trio of French businessmen plan counter-offer for Casino	23-06-08	RE
Trio of French businessmen plan counter-offer for Casino	23-06-08	RE
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
France's InVivo offers close to $1 bln for Australia's United Malt	23-03-27	RE
France's InVivo placed bid for Australia's United Malt -report	23-03-27	RE
Sector Update: Healthcare Stocks Stumble Late	23-03-09	MT
Sector Update: Health Care	23-03-09	MT
Top Midday Decliners	23-03-09	MT
InVivo Therapeutics Says Study of Neuro-Spinal Scaffold Device Didn't Achieve Primary Endpoint; Shares Fall	23-03-09	MT
InVivo Therapeutics Says Study of Neuro-Spinal Scaffold Device Didn't Achieve Primary Endpoint; Shares Halted	23-03-09	MT

Chart InVivo Therapeutics Holdings Corp.

Duration

Period

Chart InVivo Therapeutics Holdings Corp.

More charts

InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by-side, healing by supporting the surrounding tissue after injury, minimizing the expansion of areas of necrosis, and providing a biomaterial substrate for the body's own healing/repair processes following injury. It is composed of two biocompatible and bioresorbable polymers that are cast to form a porous investigational product: Poly lactic-co-glycolic acid and Poly-L-Lysine. Poly lactic-co-glycolic acid is a polymer that is used in resorbable sutures and provides biocompatible support for Neuro-Spinal Scaffold implants and Poly-L-Lysine is a positively charged polymer used to coat surfaces.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INVIVO THERAPEUTICS HOLDINGS CORP.	-49.32%	1.12M
THERMO FISHER SCIENTIFIC	+8.07%	218B
DANAHER CORPORATION	+6.59%	182B
INTUITIVE SURGICAL, INC.	+11.26%	132B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.98B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	47.59B
AGILENT TECHNOLOGIES, INC.	-0.93%	39.96B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.22B
RESMED, INC.	+26.76%	26.94B